Get started
Author

Jean de Dieu Iragena

Observed names: Iragena, Jean De Dieu, J.D.D. Iragena, Jean De Dieu Iragena, de Dieu Iragena J
ORCID: 0000-0002-5237-9775
Observed ORCID: 0000-0002-5237-9775
OpenAlex ID: A5067917653
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
2012 · Karin Weyer, Fuad Mirzayev, et al. · European Respiratory Journal · 258
PDF
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs
2008 · L Barrera, E Cooreman, et al. · 227
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial
2020 · Willy Ssengooba, Jean de Dieu Iragena, et al. · Journal of Clinical Microbiology · 35
Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017
2019 · Alain Farra, Alexandre Manirakiza, et al. · Open Forum Infectious Diseases · 20
PDF
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field
2025 · Sheila F Lumley, Jolynne Mokaya, et al. · The Lancet Microbe · 15
Implementation of quality management systems and progress towards accreditation of National Tuberculosis Reference Laboratories in Africa
2017 · Heidi Albert, Jean De Dieu Iragena, et al. · African Journal of Laboratory Medicine · 10
PDF
Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic
2023 · Alain Farra, Karen Koula, et al. · PLOS Global Public Health · 6
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
2021 · Willy Ssengooba, Jean de Dieu Iragena, et al. · Open Forum Infectious Diseases · 5
PDF
Diversity, geographical distribution and predictive factors of Hepatitis C virus genotypes and subtypes in Rwanda
2024 · Jean Claude Uwimbabazi, Léon Mutesa, et al. · Acta Tropica · 3
PDF
Tuberculosis laboratory capacity building in the WHO African Region: The past, the present and the future: A Viewpoint
2025 · Jean de Dieu Iragena, Achilles Katamba, et al. · PLOS Global Public Health · 2
PDF
Predisposing, enabling, and need factors influencing rapid uptake of the world health organization-endorsed TB diagnostic technologies in Africa
2025 · Jean de Dieu Iragena, Achilles Katamba, et al. · BMC Infectious Diseases · 2
PDF
Uptake and rollout of the World Health Organization-endorsed technologies for Tuberculosis diagnosis in Africa: a literature review of international evidence 2007-2021
2025 · Jean De Dieu Iragena, Esther Uwimaana, et al. · African Health Sciences
PDF
Uptake and rollout of the World Health Organization-endorsed technologies for Tuberculosis diagnosis in Africa: A systematic review of international evidence 2007-2021
2025 · Jean de Dieu Iragena, Esther Uwimaana, et al. · medRxiv
PDF
Implementation of WHO-endorsed technologies for TB diagnosis in Africa: opportunities, strengths and challenges
2022 · Jean de Dieu Iragena · http://isrctn.com/
Diagnostic of HIV, TB and hepatitis using GeneXpert platform in Africa: challenges, lessons learnt and way forward in the era of the sustainable development goal
2019 · J.D.D. Iragena, F. Jallow, et al. · Journal of Virus Eradication
PDF
Rational use of DST in programmes for control of drug-resistant TB
2008 · L Barrera, E Cooreman, et al.
Works count: 17
Citation count: 583
H-index: 6
I10-index: 6
Year
Topic
Type